Table of Content

1 Age Related Macular Degeneration Drug Market Introduction and Overview
1.1 Age Related Macular Degeneration Drug Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Age Related Macular Degeneration Drug Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type
3 Global Age Related Macular Degeneration Drug Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Age Related Macular Degeneration Drug Market Size (2019-2024)
4.2 Age Related Macular Degeneration Drug Growth Trends Analysis by Regions
4.2.1 Age Related Macular Degeneration Drug Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Age Related Macular Degeneration Drug Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Age Related Macular Degeneration Drug Market Size (2019-2024)
4.2.4 Europe Age Related Macular Degeneration Drug Market Size (2019-2024)
4.2.5 Asia-Pacific Age Related Macular Degeneration Drug Market Size (2019-2024)
4.2.6 Latin America Age Related Macular Degeneration Drug Market Size (2019-2024)
4.2.7 Middle East & Africa Age Related Macular Degeneration Drug Market Size (2019-2024)
5 North America
5.1 North America Age Related Macular Degeneration Drug Revenue by Countries
5.1.1 North America Age Related Macular Degeneration Drug Revenue by Countries (2019-2024)
5.2 North America Age Related Macular Degeneration Drug Revenue by Types
5.3 North America Age Related Macular Degeneration Drug Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Age Related Macular Degeneration Drug Revenue by Countries
6.1.1 Asia Pacific Age Related Macular Degeneration Drug Revenue by Countries (2019-2024)
6.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Types
6.3 Asia Pacific Age Related Macular Degeneration Drug Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Age Related Macular Degeneration Drug Revenue by Countries
7.1.1 Europe Age Related Macular Degeneration Drug Revenue by Countries (2019-2024)
7.2 Europe Age Related Macular Degeneration Drug Revenue by Types
7.3 Europe Age Related Macular Degeneration Drug Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Age Related Macular Degeneration Drug Revenue by Countries
8.1.1 Latin America Age Related Macular Degeneration Drug Revenue by Countries (2019-2024)
8.2 Latin America Age Related Macular Degeneration Drug Revenue by Types
8.3 Latin America Age Related Macular Degeneration Drug Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Age Related Macular Degeneration Drug Revenue by Countries
9.1.1 Middle East & Africa Age Related Macular Degeneration Drug Revenue by Countries (2019-2024)
9.2 Middle East & Africa Age Related Macular Degeneration Drug Revenue by Types
9.3 Middle East & Africa Age Related Macular Degeneration Drug Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Age Related Macular Degeneration Drug Market Competition, by Players
10.1 Global Age Related Macular Degeneration Drug Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Age Related Macular Degeneration Drug Players Market Share in 2023
10.2.2 Top 6 Age Related Macular Degeneration Drug Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Age Related Macular Degeneration Drug Players Head Office, Business Provided
10.4 Age Related Macular Degeneration Drug Mergers & Acquisitions
10.5 Age Related Macular Degeneration Drug New Entrants and Expansion Plans
11 Players Profiles11.1 Applied Genetic Technologies Corp
11.1.1 Applied Genetic Technologies Corp Company Profile
11.1.2 Age Related Macular Degeneration Drug Product Overview
11.1.3 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.1.4 Applied Genetic Technologies Corp Business Overview
11.1.5 Recent Developments and Plans
11.2 Astellas Pharma Inc
11.2.1 Astellas Pharma Inc Company Profile
11.2.2 Age Related Macular Degeneration Drug Product Overview
11.2.3 Astellas Pharma Inc Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.2.4 Astellas Pharma Inc Business Overview
11.2.5 Recent Developments and Plans
11.3 Benitec Biopharma Ltd
11.3.1 Benitec Biopharma Ltd Company Profile
11.3.2 Age Related Macular Degeneration Drug Product Overview
11.3.3 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.3.4 Benitec Biopharma Ltd Business Overview
11.3.5 Recent Developments and Plans
11.4 Biokine Therapeutics Ltd
11.4.1 Biokine Therapeutics Ltd Company Profile
11.4.2 Age Related Macular Degeneration Drug Product Overview
11.4.3 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.4.4 Biokine Therapeutics Ltd Business Overview
11.4.5 Recent Developments and Plans
11.5 Crinetics Pharmaceuticals Inc
11.5.1 Crinetics Pharmaceuticals Inc Company Profile
11.5.2 Age Related Macular Degeneration Drug Product Overview
11.5.3 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.5.4 Crinetics Pharmaceuticals Inc Business Overview
11.5.5 Recent Developments and Plans
11.6 Critical Pharmaceuticals Ltd
11.6.1 Critical Pharmaceuticals Ltd Company Profile
11.6.2 Age Related Macular Degeneration Drug Product Overview
11.6.3 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.6.4 Critical Pharmaceuticals Ltd Business Overview
11.6.5 Recent Developments and Plans
11.7 Daiichi Sankyo Company Ltd
11.7.1 Daiichi Sankyo Company Ltd Company Profile
11.7.2 Age Related Macular Degeneration Drug Product Overview
11.7.3 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.7.4 Daiichi Sankyo Company Ltd Business Overview
11.7.5 Recent Developments and Plans
11.8 Diffusion Pharmaceuticals Inc
11.8.1 Diffusion Pharmaceuticals Inc Company Profile
11.8.2 Age Related Macular Degeneration Drug Product Overview
11.8.3 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.8.4 Diffusion Pharmaceuticals Inc Business Overview
11.8.5 Recent Developments and Plans
11.9 Dong-A Socio Holdings Co Ltd
11.9.1 Dong-A Socio Holdings Co Ltd Company Profile
11.9.2 Age Related Macular Degeneration Drug Product Overview
11.9.3 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.9.4 Dong-A Socio Holdings Co Ltd Business Overview
11.9.5 Recent Developments and Plans
11.10 Eleven Biotherapeutics Inc
11.10.1 Eleven Biotherapeutics Inc Company Profile
11.10.2 Age Related Macular Degeneration Drug Product Overview
11.10.3 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.10.4 Eleven Biotherapeutics Inc Business Overview
11.10.5 Recent Developments and Plans
11.11 Elsalys Biotech SAS
11.11.1 Elsalys Biotech SAS Company Profile
11.11.2 Age Related Macular Degeneration Drug Product Overview
11.11.3 Elsalys Biotech SAS Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.11.4 Elsalys Biotech SAS Business Overview
11.11.5 Recent Developments and Plans
11.12 Lupin Ltd
11.12.1 Lupin Ltd Company Profile
11.12.2 Age Related Macular Degeneration Drug Product Overview
11.12.3 Lupin Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
11.12.4 Lupin Ltd Business Overview
11.12.5 Recent Developments and Plans
12 Global Age Related Macular Degeneration Drug Forecast Market Analysis by Type
12.1 Global Age Related Macular Degeneration Drug Revenue Market Forecast by Type (2024-2030)
13 Global Age Related Macular Degeneration Drug Forecast Market Analysis by Application
13.1 Age Related Macular Degeneration Drug Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Age Related Macular Degeneration Drug Forecast Market Size (2024-2030)
14.2 Age Related Macular Degeneration Drug Growth Trends Forecast Analysis by Regions
14.2.1 Age Related Macular Degeneration Drug Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Age Related Macular Degeneration Drug Forecast Market Size (2024-2030)
14.2.3 Europe Age Related Macular Degeneration Drug Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Age Related Macular Degeneration Drug Forecast Market Size (2024-2030)
14.2.5 Latin America Age Related Macular Degeneration Drug Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Age Related Macular Degeneration Drug Forecast Market Size (2024-2030)
15 Age Related Macular Degeneration Drug Industry Dynamic Analysis
15.1 Age Related Macular Degeneration Drug Market Trends Analysis
15.2 Age Related Macular Degeneration Drug Market Drivers Analysis
15.3 Age Related Macular Degeneration Drug Market Challenges Analysis
15.4 Age Related Macular Degeneration Drug Market Restraints Analysis